Medical System Network Co (TSE:4350) Research & Development: 円0 Mil (TTM As of Mar. 2026)


TSE:4350 Medical System Network Co Ltd TSE:4350
64 GF Score
Price 円461.00
GF Value 円521.78
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Medical System Network Co Research & Development?

Medical System Network Co TSE:4350 -0.86% 64 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:4350 with a GF Score™ of 64/100 and a GF Value™ of 円521.78 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Medical System Network Co's Research & Development for the three months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Medical System Network Co  (TSE:4350) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Medical System Network Co Research & Development Related Terms

Medical System Network Co Research & Development Historical Data

* Premium members only.

The historical data trend for Medical System Network Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical System Network Co Research & Development Chart

Medical System Network Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medical System Network Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4350
64GF Score
Medical System Network Co Ltd TSE:4350
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical System Network Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Medical System Network Co (TSE:4350) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Medical System Network Co and its competitors.
Is Medical System Network Co's Research & Development too high?
Medical System Network Co's current Research & Development is 円0 Mil. Overall, Medical System Network Co has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical System Network Co's Research & Development compare to competitors?
Medical System Network Co's Research & Development of 円0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Medical System Network Co and its competitors. Medical System Network Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical System Network Co stock overvalued right now?
Based on GuruFocus' analysis, Medical System Network Co (TSE:4350) is currently considered Modestly Undervalued. The stock's GF Value™ is 円521.78, compared to a current price of 円461.00 — trading 11.6% below its estimated fair value. The current Research & Development is 円0 Mil. Medical System Network Co's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Medical System Network Co (TSE:4350), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical System Network Co (TSE:4350) Overvalued in 2026?

Based on GuruFocus' analysis, Medical System Network Co stock appears to be undervalued. The current stock price of 円461.00 is trading 11.6% below its estimated GF Value™ of 円521.78. GuruFocus considers Medical System Network Co to be Modestly Undervalued.

Key valuation signals for TSE:4350:

  • Research & Development: 円0 Mil
  • GF Value™: 円521.78 vs. price of 円461.00 (11.6% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the TSE:4350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medical System Network Co Business Description

Address AKK floor Building 6 at 3-chome, Kita 24-jo Nishi 10, Chuo-ku, Sapporo, JPN, 060-0010
Medical System Network Co Ltd is involved in its network business of dispensing pharmacy business. It also operates a network database used by pharmacies to access patients' prescriptions. It operates through the following business divisions: Pharmaceutical Product Network; Dispensing Pharmacy; Leasing and Equipment-related Business; Food Supply business and others.
64GF Score

Get the complete analysis for TSE:4350

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円461.00
Price
円521.78
GF Value